Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “probiotics” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 12
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 12 pipeline programs matching "probiotics" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

12 results for “probiotics” Back to intelligence hub

Search results

  1. probiotics, antibiotics or antidepressants

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial
  2. Probiotics Compound (Biolosion)

    Sun Yat-sen University

    Advanced Urothelial Carcinoma

    phase 2 small molecule active

    1 trial
  3. Probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Kidney Disease

    approved other completed

    1 trial
  4. Akkermansia Probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colo-rectal Cancer

    other active

    1 trial
  5. Probiotics

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    other terminated

    1 trial
  6. Probiotics

    Sun Yat-sen University

    Cardiometabolic Risk Factors

    other completed

    1 trial
  7. Probiotics daily

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2

    other completed

    1 trial
  8. QiMeiYan Probiotics

    Chongqing Precision Biotech Co., Ltd

    IBS - Irritable Bowel Syndrome

    other completed

    1 trial
  9. Wonderlab Kids instant probiotics

    Chongqing Precision Biotech Co., Ltd

    Immunity

    other completed

    1 trial
  10. probiotics

    Hospital Authority, Hong Kong

    Parkinson's Disease (PD)

    other terminated

    1 trial
  11. probiotics

    The First People's Hospital of Lianyungang

    Ulcerative Colitis

    other active

    1 trial
  12. probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Necrotizing Enterocolitis

    other active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.